Cardiology
Heart Failure — GDMT Optimisation
ESC 2021 / NICE NG106 — four pillars of HFrEF therapy, titration, monitoring, device therapy.
Source: ESC 2021 HF; NICE NG106
Step 1 of ~7
info
Confirm HFrEF / HFmrEF / HFpEF
Diagnosis: clinical + NT-proBNP/BNP + echo (LVEF). HFrEF (LVEF ≤40%); HFmrEF (41–49%); HFpEF (≥50% + structural/diastolic abnormality + raised NP). Classify NYHA. Identify aetiology: ischaemic, valvular, hypertensive, arrhythmia-mediated, infiltrative, peripartum, congenital, idiopathic DCM.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only. Always apply local guidelines and clinical judgement.